Merit and demerit effects of silver nanoparticles in the bioperformance of an electrodeposited hydroxyapatite: nanosilver composite coating
Source abstract
Abstract
For this research, TiAlZr specimens were covered with a hydroxyapatite–silver nanoparticles composite coatings (nAg-HA) prepared by pulse electrodeposition. The morphological texture of the nAg-HA nanoparticles on TiAlZr surface was investigated with scanning electron microscopy and energy dispersive X-ray spectroscopy. Electrochemical parameters from dynamic polarization tests performed in Ringer’s solution indicate better anticorrosive properties for the TiAlZr alloy after nAg-HA electrodeposition. Bacteriological experiments performed in vitro demonstrate the efficacy of TiAlZr implants coated with nAg-HA against the growth of Escherichia coli bacteria quantified in a 98 % inhibition of Escherichia coli growth. The biocompatibility tests regarding cell adherence, proliferation, and viability of coating (also by means of Reverse Transcription Polymerase Chain Reaction—RT-PCR) completed the characterization of the coating, enabling us to discuss the merit and demerit effects of Ag nanoparticles (nAg) effects on bioperformance. Based on experimental and literature data, the coating could be considered a passive–active structure.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Nanoparticles: synthesis and applications · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML (2009) Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev 61:457–46610.1016/j.addr.2009.03.010 ↗
2. AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S (2009) Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:279–29010.1021/nn800596w ↗
3. Balagna C, Vitale-Brovarone C, Miola M, Verne E, Canuto RA, Saracino S, Muzio G, Fucale G, Maina G (2011) Biocompatibility and antibacterial effect of silver doped 3D-glass-ceramic scaffolds for bone grafting. J Biomater Appl 25:595–61710.1177/0885328209356603 ↗
4. Ballare J, Manjubala I, Schreiner WH, Orellano JC, Fratzl P, Cere S (2010) Improving the osteointegration and bone–implant interface by incorporation of bioactive particles in sol–gel coatings of stainless steel implants. Acta Biomater 6:1601–160910.1016/j.actbio.2009.10.015 ↗
5. Cao XL, Cheng C, Ma YL, Zhao CS (2010) Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. J Mater Sci Mater Med 21:2861–286810.1007/s10856-010-4133-2 ↗
6. Chen Y, Zheng X, Xie Y, Ding C, Ruan H, Fan C (2008) Anti-bacterial and cytotoxic properties of plasma sprayed silver-containing HA coatings. J Mater Sci Mater Med 19:3603–360910.1007/s10856-008-3529-8 ↗
7. Chen Y, Zheng X, Xie Y, Ji H, Ding C (2009) Antibacterial properties of vacuum plasma sprayed titanium coatings after chemical treatment. Surf Coat Technol 204:685–69010.1016/j.surfcoat.2009.09.010 ↗
8. Demetrescu I (2008) Passive and bioactive films on implant materials and their efficiency in regenerative medicine. Mol Cryst Liq Cryst 486:110–11910.1080/15421400801917858 ↗
9. Demetrescu I, Pirvu C, Mitran V (2010) Effect of nano: topographical features of Ti/TiO2 electrode surface on cell response and electrochemical stability in artificial saliva. Bioelectrochemistry 79:122–12910.1016/j.bioelechem.2010.02.001 ↗
10. Hoonacker AV, Englebienne P (2006) Revisiting silver nanoparticle chemical synthesis and stability by optical spectroscopy. Curr Nanosci 2:359–37110.2174/157341306778699310 ↗
11. Hsu SH, Tseng HJ, Lin YC (2010) The biocompatibility and antibacterial properties of waterborne polyurethane-silver nanocomposites. Biomaterials 31:6796–680810.1016/j.biomaterials.2010.05.015 ↗
12. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975–98310.1016/j.tiv.2005.06.034 ↗
13. Iafisco M, Bosco R, Leeuwenburgh SCG, Van den Beucken JJJP, Jansen JA, Prat M, Roveri N (2011) Electrostatic spray deposition of biomimetic nanocrystalline apatite coatings onto titanium. Adv Eng Mater. doi: 10.1002/adem.201180062
14. Ionita D, Grecu M, Ungureanu C, Demetrescu I (2011a) Antimicrobial activity of the surface coatings on TiAlZr implant biomaterial. J Biosci Bioeng 112:6630–663410.1016/j.jbiosc.2011.07.022 ↗
15. Ionita D, Grecu M, Ungureanu C, Demetrescu I (2011b) Modifying the TiAlZr biomaterial surface with coating, for a better anticorrosive and antibacterial performance. Appl Surf Sci 257:9164–916810.1016/j.apsusc.2011.05.125 ↗
16. Kunin CM (1987) Detection, prevention and management of urinary tract infection. Lea & Febiger, Philadelphia, PA
17. Lubick N (2008) Nanosilver toxicity: ions, nanoparticles—or both? Environ Sci Technol 42:861710.1021/es8026314 ↗
18. Marambio-Jones C, Hoek EMV (2010) A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12:1531–155110.1007/s11051-010-9900-y ↗
19. Maury F, Mungkalasari J (2009) Chemical vapor deposition of TiO2 for photocatalytic applications and biocidal surfaces. Key Eng Mater 415:1–410.4028/www.scientific.net/KEM.415.1 ↗
20. Moa A, Liao J, Xu W, Xian S, Li Y, Bai S (2008) Preparation and antibacterial effect of silver–hydroxyapatite/titania nanocomposite thin film on titanium. Appl Surf Sci 255:435–43810.1016/j.apsusc.2008.06.083 ↗
21. Morgan MLD (1998) Tetrazolium (MTT) Assay for cellular viability and activity methods. In: Mol. Biol., Polyamine protocols, Part VI, ed. Humana Press Inc. pp 179–184
22. Narayan RJ, Monteiro-Riviere NA, Brigmon RL, Pellin MJ, Elam JW (2009) Atomic layer deposition of TiO2 thin films on nanoporous alumina templates: medical applications. JOM J Miner Metall Mater 61:12–1610.1007/s11837-009-0081-z ↗
23. Narayanan R, Seshadri SK (2008) Point defect model and corrosion of anodic oxide coatings on Ti–6Al–4 V. Corros Sci 50:1521–152910.1016/j.corsci.2008.02.023 ↗
24. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311:622–62710.1126/science.1114397 ↗
25. Oliveira PT, Zalzal SF, Irie K, Nanci A (2003) Early expression of bone matrix proteins in osteogenic cell cultures. J Histochem Cytochem 51:633–64110.1177/002215540305100509 ↗
26. Papp T, Schiffmann D, Weiss D, Castranova V, Vallyathan V, Rahman Q (2008) Human health implications of nanomaterial exposure. Nanotoxicology 2:9–2710.1080/17435390701847935 ↗
27. Park EJ, Yi J, Kim Y, Choi K, Park K (2010) Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24:872–87810.1016/j.tiv.2009.12.001 ↗
28. Popa MV, Demetrescu I, Suh SH, Vasilescu E, Drob P, Ionita D, Vasilescu C (2007) Monitoring of titanium base alloys–biofluids interface. Bioelectrochemistry 71:126–13410.1016/j.bioelechem.2007.02.007 ↗
29. Rameshbabu N, Kumar TSS, Prabhakar TG, Sastry VS, Murty KVGK, Rao KP (2007) Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization. J Biomed Mater Res-A 80A:581–59110.1002/jbm.a.30958 ↗
30. Roco MC (2004) Nanoscale science and engineering: unifying and transforming tools. AIChE J 50:890–89710.1002/aic.10087 ↗
31. Simchi A, Tamjid E, Pishbin F, Boccaccini AR (2011) Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. Nanomed 7:22–3910.1016/j.nano.2010.10.005 ↗
32. Sondi I, Salopek-Sondi B (2004) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci 275:177–18210.1016/j.jcis.2004.02.012 ↗
33. Sotiriou GA, Pratsinis SE (2010) Antibacterial activity of nanosilver ions and particles. Environ Sci Technol 44:5649–565410.1021/es101072s ↗
34. Stickler DJ (2000) Biomaterials to prevent nosocomial infections: is silver the gold standard? Curr Opin Infect Dis 13:389–39310.1097/00001432-200008000-00011 ↗
35. Stratton TR, Howarter JA, Allison BC, Applegate BM, Youngblood JP (2010) Structure–activity relationships of antibacterial and biocompatible copolymers. Biomacromolecules 11:1286–129010.1021/bm1000839 ↗
36. Subramanian V, Youtie J, Porter AL, Shapira P (2010) Is there a shift to “active nanostructures”? J Nanopart Res 12:1–1010.1007/s11051-009-9729-4 ↗
37. Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J et al (2009) Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452–46110.1093/toxsci/kfn246 ↗
38. Titorencu I, Jinga VV, Constantinescu E, Gafencu AV, Ciohodaru C, Manolescu I, Zaharia C, Simionescu M (2007) Proliferation, differentiation and characterization of osteoblasts from human bone marrow mesenchymal cells. Cytotherapy 9:682–69610.1080/14653240701561329 ↗
39. Vasilescu C, Drob P, Vasilescu E, Demetrescu I, Ionita D, Prodana M, Drob SI (2011) Characterisation and corrosion resistance of the electrodeposited hydroxyapatite and bovine serum albumin/hydroxyapatite films on Ti–6Al–4 V–1Zr alloy surface. Corros Sci 53:992–99910.1016/j.corsci.2010.11.033 ↗
40. Watari F (2010) Bioreactive nature of nanobiomaterials. Nanobiomedicine 1:2–8
41. Watari F, Takashi N, Yokoyama A, Uo M, Akasaka T, Sato T, Abe S, Totsuka Tohji K (2009) Material nanosizing effect on living organisms: non-specific, biointeractive, physical size effects. J R Soc Interface 6:371–38810.1098/rsif.2008.0488.focus ↗
42. Yaser G, Melanie JC, Karin AH, Gordon WB (2012) Development of a hydroxyapatite coating containing silver for the prevention of peri-prosthetic infection. J Orthop Res 30:356–36310.1002/jor.21543 ↗